Loading…

Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis

Background The effect of Helicobacter pylori ( H. pylori ) eradication on gastric cancer (GC) prevention is controversial. Intestinal metaplasia (IM) seems to be a “point of no return” in the precancerous cascade. We performed a meta-analysis of randomized controlled trials (RCTs) to illustrate this...

Full description

Saved in:
Bibliographic Details
Published in:Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016-01, Vol.19 (1), p.166-175
Main Authors: Chen, Hai-Ning, Wang, Zhu, Li, Xiao, Zhou, Zong-Guang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The effect of Helicobacter pylori ( H. pylori ) eradication on gastric cancer (GC) prevention is controversial. Intestinal metaplasia (IM) seems to be a “point of no return” in the precancerous cascade. We performed a meta-analysis of randomized controlled trials (RCTs) to illustrate this issue. Materials and Methods The MEDLINE, EMBASE, Cochrane Library were searched for relevant RCTs that were published in any language up to March 2014. By dividing participants into subgroups based on their baseline diagnoses as group
ISSN:1436-3291
1436-3305
DOI:10.1007/s10120-015-0462-7